Skip to main content

Congress overrides Bush on Medicare

The following is a press release that came from the American Thoracic Society. It involves two issues of importance to us. First, without this action the amount of payment doctors recieved from treating patients on Medicare would have been cut. Trust me - it isn't the docs getting rich off of Medicare patients. And to penalize them for treating Medicare patients by not paying market rates would mean that Medicare patients would find it harder and harder to find a doctor willing to take them on.

For us, throw in an ultra rare syndrome (thus more time consuming) and this would have been a problem for many of those with HPS.

The second issue has to do with pulmonary rehabilitation. By getting Medicare to cover pulmonary rehabilitation, hopefully other insurers will join in as well. The benefits are real from what I've seen first hand. It's an issue the HPS Network has worked on with the ATS in the past so it's another victory for the year.

American Thoracic Society Applauds the Enactment of the Medicare Improvements for Patients and Providers Act (H.R. 6331)

Today, Congress voted to override President Bush's veto of the Medicare Improvements for Patients and Providers Act (H.R. 6331). Congressional action today averted the scheduled 10.6% cut in Medicare physician payments. This represents an important victory for doctors and their patients.

Congress also enhanced the Medicare program in important ways, most notably adding pulmonary rehabilitation services as a covered benefit under Medicare. Along with fighting for fair reimbursement for our members, the Society's Government Relations Office, in Washington, has long worked with individual ATS members, PAR, the Council of Chapter Representatives, the Clinicians Advisory Committee, and sibling organizations to have this important therapy for COPD and other respiratory diseases covered uniformly by Medicare.

I know I speak for our members, as well as their patients, in thanking our Congressional champions Sen. Mike Crapo, Sen. Blanche Lincoln, Rep. John Lewis and Rep. Chip Pickering for their tireless efforts to secure Medicare coverage of pulmonary rehabilitation for patients with COPD. Their leadership was crucial in ensuring Medicare coverage of pulmonary rehabilitation.

Jo Rae Wright, PhD
President

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria